Women's cardiovascular health in the age of artificial intelligence: a vital challenge with promise

Cardiovascular disease remains the leading cause of death among women worldwide. Atypical symptoms, late diagnoses: artificial intelligence (AI) is finally paving the way for fairer, more accurate management.
Towards more precise cardiovascular medicine
AI can analyze thousands of pieces of information at once: test results, medical data or even measurements taken by connected objects. As a result, it spots subtle signs and detects risks that doctors sometimes can't detect with the naked eye. By drawing on more varied data that is more representative of women, it can better anticipate the onset of heart disease, while taking into account female specificities, such as hormones or genetics.
AI offers a new opportunity in the face of cardiovascular disease, enabling much more personalized care. Every woman's heart reacts differently according to her age, hormones or history. By analyzing all these elements, AI can recommend more appropriate treatments, adjust medication doses and offer more precise monitoring. In some hospitals, AI tools already continuously monitor cardiac data, and send alerts in the event of anomalies. This monitoring is particularly useful during pregnancy, a period when the heart is put to the test.
A revolution to support, not replace.
For this revolution to live up to all its promises, several challenges remain. Data quality and diversity are essential. If algorithms are trained on groups that are too small or unrepresentative, they risk reproducing current biases.
The confidentiality of personal data and the security of AI systems must also be guaranteed. What's more, healthcare professionals need to understand how these tools work, so they can validate their recommendations and, if necessary, question them in order to regain human control. Integrating these technologies into daily practice requires time and resources. Healthcare teams need to be trained in the use of AI. Patients, for their part, need to be reassured about how their data will be used.
Finally, close collaboration between doctors, researchers, engineers and public authorities is essential. Together, they can put in place an ethical, transparent and secure framework to guarantee the trust of patients and the general public.
Conclusion
Artificial intelligence will not replace the role of caregivers, but it can decisively support them. By improving screening, diagnosis, treatment personalization and prevention, it represents a unique opportunity to close the gap in the management of cardiovascular disease in women. What remains is to ensure that the burgeoning AI revolution is carried out ethically and responsibly. In this way, every female heartbeat of the 18,000 women who have benefited from the Act for Women's Hearts program can be even better heard, understood and protected.

More and more support actions

A convivial summer evening devoted to French chanson drew several hundred participants to Gigondas (84) on August 8, supported by Catherine Orphelin, Director of Agir pour le Cœur des Femmes. The Charity Run organized on October 8 by the DDRS Club at Polytech Paris Saclay (77), brought together some [...]

Journal du Dimanche Newspaper Article

Media

These unprecedented times have brought us back to what is most essential in life: human beings, with our most precious and fragile resource, our health. COVID-19, this visible pandemic that’s terrifying many, has forced us to take time for reflection, introspection and interrogation. Let’s use [...]

A healthy heart

Pr Claire Mounier-Vehier took part in the program "Un coeur en bonne santé", directed by Setti Dali and broadcast on France 5. Michel Cymes and his team followed 3 patients over a 3-month period, helping them to take an active preventive approach: from fractional exercise to new ways of eating, they [...]